医学
阿替唑单抗
贝伐单抗
肝细胞癌
肿瘤科
内科学
癌
化疗
癌症
彭布罗利珠单抗
免疫疗法
作者
Richard S. Finn,Shukui Qin,Masafumi Ikeda,Peter R. Galle,Michel Ducreux,Tae-You Kim,Masatoshi Kudo,В. В. Бредер,Philippe Merle,Ahmed O. Kaseb,Daneng Li,Wendy Verret,Derek-Zhen Xu,Sairy Hernandez,Juan Liu,Chen Huang,Sohail Mulla,Yulei Wang,Ho Yeong Lim,Andrew X. Zhu,Ann‐Lii Cheng
标识
DOI：10.1056/nejmoa1915745
摘要
The combination of atezolizumab and bevacizumab showed encouraging antitumor activity and safety in a phase 1b trial involving patients with unresectable hepatocellular carcinoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI
shinysparrow
gjww
benben
maox1aoxin
FIN
wk990240
benben055
SOLOMON
紫金大萝卜
不倦
坚强的广山
kedaya
草拟大坝
热忱未减
寻寻觅觅呢
纳兰若微
充电宝
敬老院1号
cctv18
CharlotteBlue
皖公网安备34019202002308
